Patient Square Capital
Patient Square Capital is a dedicated health care investment firm that partners with management teams whose products, services, and technologies improve health. The firm aims to achieve strong investment returns by collaborating with high-quality, growth-oriented companies and top-tier management teams. Patient Square utilizes deep industry expertise, a broad network of relationships, and a partnership approach to make investments in companies that strive to improve patient lives, strengthen communities, and create a healthier world.
Portfolio
Apollo Therapeutics focuses on translating fundamental medical research into medicines through a hub-and-spoke approach. The company has a broad and diversified pipeline with over 20 programs.
#Biopharmaceutical
Alladapt is developing prescription therapeutics to address IgE-mediated food allergy. The company is conducting the Harmony Study, a Phase 1/2 trial, and the Encore Study, an open-label extension study.
#Biopharmaceutical
CAMP4 is harnessing the power of RNA to restore healthy protein expression. The company is advancing its regRNA Actuating Platform to treat genetic diseases.
#Biotechnology
Kriya is developing gene therapies for ophthalmology, neurology, and metabolic disease. The company has raised over $600 million in committed capital.
#Biopharmaceutical
Eargo is a medical device company focused on improving the quality of life for people with hearing loss. The company received up to $125 million in strategic investment from Patient Square Capital.
#Medical Device
Hanger provides orthotic and prosthetic services and solutions. It was acquired by Patient Square Capital for $18.75 per share in cash, with a total enterprise value of approximately $1.25 billion.
#Orthotic and Prosthetic Services
Key People
Managing Partner
Founding Partner
Founding Partner
Founding Partner and General Counsel
Founding Partner